I have always thought, along with other colleagues for a long time, that you can start identifying groups that have lived with obesity for a very long period of time and they would somehow present differently metabolically and so on, and it would give us an understanding of what treatments would be better for someone, let's say, with long-term obesity versus someone with short-term obesity
FDA Center for Drug Evaluation and Research
402 : 615622 Onofrj M, Bodis-Wollner I, Pola P, Calvani M
Esto ha llevado a mucha gente a asociar la L-carnitina principalmente con la quema de grasa
Acetyl-L-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats Neurosci Lett 1989
The Ofev patent expiry in January 2026 becomes a positioning opportunity, not a problem